Significance of stromal decorin expression during the progression of breast cancer

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2003-2008

  Oda, Goshi ^a   Sato, Takanobu ^a   Ishikawa, Toshiaki ^a   Kawachi, Hiroshi ^a   Nakagawa, Tsuyoshi ^a   Kuwayama, Takashi ^a   Ishiguro, Megumi ^a   Iida, Satoru ^a   Uetake, Hiroyuki ^a   Sugihara, Kenichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Cancer stroma; Decorin; Extracellular matrix; Proteoglycan

Indexed keywords

DECORIN; HORMONE RECEPTOR;

ADULT; AGE; AGED; BREAST CANCER; CANCER SURGERY; CARCINOGENESIS; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE LEVEL; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DECORIN; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84868152795     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2040     Document Type: Conference Paper

References (26)

1. Kim SH, Turnbull J and Guimond S: Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 209:139-151, 2011.
2. Goldoni S and Iozzo R: Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs. Int J Cancer 123:2473-2479, 2008.
3. Iozzo R: Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609-652, 1998. (Pubitemid 28411140)
4. Reed CC and Iozzo RV: The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 19:249-255, 2002. (Pubitemid 37174552)
5. Yamaguchi Y, Mann D and Ruoslahti E: Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346:281-284, 1990.
6. Araki K, Wakabayashi H, Shintani K, et al: Decorin suppresses bone metastasis in a breast cancer cell line. Oncology 77:92-99, 2009.
7. Goldoni S, Seidler D, Heath J, et al: An antimetastatic role for decorin in breast cancer. Am J Pathol 173:844-855, 2008.
8. Burstein HJ, Polyak K, Wong JS, Lester SC and Kaelin CM: Ductal carcinoma in situ of the breast. N Engl J Med 350:1430-1441, 2004. (Pubitemid 38419997)
9. Sobin LH and Wittekind C (eds): TNM Classification of Malignant Tumors. 6th edition. John Wiley & Sons, New York, 2002.
10. Augoff K, Grabowski K, Rabczynski J, Kolondra A, Tabola R and Sikorski A: Expression of decorin in esophageal cancer in relation to the expression of three isoforms of transforming growth factor-beta (TGF-beta1, -beta2, and -beta3) and matrix metalloproteinase-2 activity. Cancer Invest 27:443-452, 2009.
11. Augoff K, Rabczynski J, Tabola R, Czapla L, Ratajczak K and Grabowski K: Immunohistochemical study of decorin expression in polyps and carcinomas of the colon. Med Sci Monit 14:CR530-CR535, 2008.
12. Ferdous Z, Wei V, Iozzo R, Höök M and Grande-Allen K: Decorin-transforming growth factor-interaction regulates matrix organization and mechanical characteristics of three-dimensional collagen matrices. J Biol Chem 282:35887-35898, 2007. (Pubitemid 350277129)
13. Ständer M, Naumann U, Dumitrescu L, et al: Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther 5:1187-1194, 1998. (Pubitemid 28448426)
14. Reiss M and Barcellos-Hoff MH: Transforming growth factorbeta in breast cancer: a working hypothesis. Breast Cancer Res Treat 45:81-95, 1997. (Pubitemid 27338535)
15. Akhurst RJ and Balmain A: Genetic events and the role of TGF beta in epithelial tumour progression. J Pathol 187:82-90, 1999. (Pubitemid 29009837)
16. Iozzo R, Moscatello D, McQuillan D and Eichstetter I: Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 274:4489-4492, 1999.
17. Csordás G, Santra M, Reed C, et al: Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 275:32879-32887, 2000.
18. Polette M, Gilbert N, Stas I, et al: Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy. Virchows Arch 424:641-645, 1994. (Pubitemid 24245336)
19. Imai K, Hiramatsu A, Fukushima D, Pierschbacher M and Okada Y: Degradation of decorin by matrix metalloproteinases: identifcation of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322:809-814, 1997. (Pubitemid 27135628)
20. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N and Okada Y: Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn J Cancer Res 87:602-611, 1996. (Pubitemid 26235551)
21. Jones JL, Glynn P and Walker RA: Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189:161-168, 1999. (Pubitemid 29448907)
22. Garbett EA, Reed MW, Stephenson TJ and Brown NJ: Proteolysis in human breast cancer. Mol Pathol 53:99-106, 2000. (Pubitemid 30183084)
23. Jiang WG, Davies G, Martin TA, et al: Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 11:6012-6019, 2005. (Pubitemid 41170333)
24. Quante M, Tu SP, Tomita H, et al: Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 19:257-272, 2011.
25. Matsumine A, Shintani K, Kusuzaki K, et al: Expression of decorin, a small leucine-rich proteoglycan, as a prognostic factor in soft tissue tumors. J Surg Oncol 96:411-418, 2007. (Pubitemid 47519447)
26. Troup S, Njue C, Kliewer E, et al: Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 9:207-214, 2003. (Pubitemid 36109735)